BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA

Reuters
15 Apr
BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA

April 15 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK:

  • CLINICAL TRIAL APPROVAL FOR HS-10529 TABLETS ISSUED BY NMPA

Further company coverage: 3692.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10